Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03284437
Other study ID # 170214-3
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date January 2021
Est. completion date April 26, 2021

Study information

Verified date July 2021
Source Mount Carmel Health System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to see how early cognitive training (participation/involvement in activities to stimulate the brain) in the Intensive Care Unit (ICU) affects the number of patients who experience delirium (confusion) and cognitive impairment (problems with thinking). Reports have shown that 30% to 80% of all ICU patients will have some type of cognitive impairment: remembering, paying attention, solving problems, organizing, and working on complex tasks for some time after they leave the hospital. Occupational therapy will do an assessment after an order is received from the doctor. The patient will be randomly placed into one of two groups. If the patient is in group A then they will continue with occupational therapy as normal. If the patient is assigned to group B then they and the family will have access to an activity cart found there in the ICU unit, directed by the nurses. The family will work with the patient on a daily basis to complete activities that are appropriate for the patient based on the occupational therapist's assessment. All patients in the study will receive medical care as usual. Information about the patient's recovery in the hospital will be collected. In addition, patients and/or their family member will complete surveys at 6 months and 1 year after enrollment to see how they have recovered and if there are continuing issues. The two groups of patients, those who received the early cognitive training and those who did not, will be compared statistically to see if there are any differences in how well they recovered. Since this intervention involving family members working with the patient has not previously been evaluated, the study will also examine the feasibility of conducting these activities in the ICU setting.


Description:

This pilot study will assess the feasibility of implementing a randomized clinical trial testing an early cognitive training program for patients in the ICU. This cognitive training program was developed at Mount Carmel Health System in conjunction with occupational therapists and has not been previously evaluated. Specific Aim 1: To evaluate whether the trial can accrue a sufficient number of patients within a reasonable time period to complete a randomized trial for efficacy. Specific Aim 2: To evaluate whether the trial can be conducted as designed. Specific Aim 3: To evaluate the likelihood that the trial can retain a sufficient number of patients through the end of follow-up. Assessments include the Montreal Cognitive Assessment Test (MoCA), Richmond Agitation and Sedation Scale (RASS), Confusion Assessment Method in the ICU (CAM-ICU) and a validated quality of life survey.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date April 26, 2021
Est. primary completion date April 26, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient must be in the intensive care unit, i.e., either the surgical intensive care unit (SICU) or medical intensive care unit (MICU). - Patient must be =18 years old. - Predicted ICU length of stay greater than 3 days. - Patient with a RASS goal of -1 to +1 at time of enrollment. - Patient's family member(s) agree to do the cognitive training for a least one hour a day (a series of items meant to focus and stretch cognitive ability) while in the ICU. The hour can be done incrementally if needed. Family member should be =18 years old. - Family who can return to the hospital at the 6 month mark to take a final MOCA test and complete a survey. Exclusion Criteria: - Patient presently on Versed, Diprivan or Ativan drips. - Patient with a history of cognitive impairment, current psychiatric diagnosis and not stable on treatment, or developmental delay. - Patient with Alzheimer's or dementia. - Patient with known active substance abuse. - Patients without family support. - Patients without the ability to return to the hospital for the 6 month visit. - Patient with history of critical care illness within the last year from time of enrollment. - Patients who have been critically ill for greater than 72 hours. - Non-English speaking individuals restricting ability to follow instructions

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Early Cognitive Training
Choose level of activity (e.g., coloring, holding objects) based on occupational therapist assessment.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mount Carmel Health System

Outcome

Type Measure Description Time frame Safety issue
Primary Percent Enrollment Percent of eligible patients who are consented and enrolled into the study. 3 Days
Primary Percent Receiving Intervention Percent of patients randomized to intervention who receive intervention One month
Secondary Montreal Cognitive Assessment Score Change in Montreal Cognitive Assessment score from baseline to 6 months 6 months